A) Intracellular abundance of citrate from control (Ctl) and BMDMs treated with Pam3, Poly I:C, or Pam3 + Poly I:C for 24 hr. (n = 7). B) State 3 respiration from permeabilized control (Ctl) and BMDMs treated with Pam3, Poly I:C, or Pam3 + Poly I:C for 24 hr. Permeabilized BMDMs were offered pyruvate/malate, citrate, glutamate/malate, or succinate/rotenone as substrates (n = 4). C) A graphical schematic depicting the labeling patterns of TCA cycle metabolites from 13C6 Glucose (black circles) and 13C5 Glutamine (grey circles). CS, citrate synthase; Aco., aconitase; IDH, isocitrate dehydrogenase; α-KGDH, alpha-ketoglutarate dehydrogenase; SCS, succinyl CoA synthetase; SDH, succinate dehydrogenase; FH, fumarate hydratase; MDH, malate dehydrogenase; AST, aspartate transaminase. D&E) Percent enrichment of denoted isotopologues from either 13C6 Glucose or 13C5 Glutamine from control (Ctl) and BMDMs treated with Pam3, Poly I:C, or Pam3 + Poly I:C for 24 hr. BMDMs were treated in unlabeled media for 16 hr. then changed to tracing media with stimuli for 6 hr. (n = 4). All data are mean ± SEM with statistical analysis conducted on data from biological replicates, each of which included multiple technical replicates, unless otherwise indicated. Statistical analysis for (A) and (B) was performed as an ordinary one-way, ANOVA followed by Tukey’s post hoc multiple comparisons test. Statistical analysis for (D) and (E) was performed as an ordinary two-way, ANOVA followed by Tukey’s post hoc multiple comparisons test.